HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Orit Picard Selected Research
Orit Picard Research Topics
Disease
17
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2023 - 09/2003
11
Crohn Disease (Crohn's Disease)
09/2023 - 12/2011
6
Inflammation (Inflammations)
01/2022 - 01/2010
5
Ulcerative Colitis
09/2023 - 01/2008
4
Necrosis
03/2024 - 04/2013
3
Neoplasms (Cancer)
09/2023 - 01/2020
2
Carcinogenesis
09/2023 - 01/2022
2
Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
09/2023 - 01/2022
2
Colonic Neoplasms (Colon Cancer)
09/2023 - 01/2022
1
Chronic Hepatitis B
11/2022
1
Human Influenza (Influenza)
01/2022
1
Tetanus
01/2022
1
Diphtheria
01/2022
1
Pancreatic Neoplasms (Pancreatic Cancer)
01/2022
1
Hepatitis B
01/2022
1
Adenocarcinoma
01/2022
1
Arthralgia (Joint Pain)
06/2020
1
Lymphoma (Lymphomas)
01/2020
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2020
1
Dysbiosis
01/2019
1
Septic Shock (Toxic Shock Syndrome)
11/2018
1
Infections
11/2018
1
Psoriasis (Pustulosis Palmaris et Plantaris)
05/2015
1
Rheumatoid Arthritis
05/2015
1
Celiac Disease (Celiac Sprue)
11/2013
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2013
1
Proctitis
01/2010
Drug/Important Bio-Agent (IBA)
10
Infliximab (Remicade)
FDA Link
01/2022 - 12/2011
8
Antibodies
IBA
09/2023 - 04/2013
6
Biomarkers (Surrogate Marker)
IBA
09/2023 - 01/2019
4
vedolizumab
IBA
05/2023 - 01/2018
4
Cytokines
IBA
05/2019 - 01/2010
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
04/2016 - 09/2014
2
Adalimumab (Humira)
FDA Link
09/2023 - 04/2016
2
Ustekinumab (CNTO 1275)
FDA Link
09/2023 - 01/2021
2
Matrix Metalloproteinases (MMPs)
IBA
09/2023 - 01/2019
2
Messenger RNA (mRNA)
IBA
01/2022 - 05/2019
2
Immunologic Factors (Immunomodulators)
IBA
01/2020 - 04/2013
1
Interleukins
IBA
12/2023
1
Matrix Metalloproteinase 7 (Matrilysin)
IBA
09/2023
1
Interleukin-12 (IL 12)
IBA
09/2023
1
Interleukin-23 (Interleukin 23)
IBA
09/2023
1
Monoclonal Antibodies
IBA
09/2023
1
RNA (Ribonucleic Acid)
IBA
11/2022
1
Hepatitis B Surface Antigens (HBsAg)
FDA Link
11/2022
1
Telomerase (Telomerase Reverse Transcriptase)
IBA
01/2022
1
Azathioprine (Imuran)
FDA Link
Generic
01/2022
1
Immunoglobulins (Immunoglobulin)
IBA
01/2022
1
Syndecan-1 (Syndecan 1)
IBA
01/2022
1
Anti-Idiotypic Antibodies
IBA
01/2020
1
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
01/2019
1
Nucleotides
IBA
11/2018
1
2-mercaptopurine
IBA
11/2018
1
Thioguanine (Tioguanine)
FDA Link
11/2018
1
Muromonab-CD3 (Muromonab CD3)
FDA Link
11/2018
1
Vaccines
IBA
11/2018
1
Mercaptopurine (6 Mercaptopurine)
FDA Link
Generic
11/2018
1
Integrins
IBA
01/2018
1
Tumor Necrosis Factors
IBA
11/2017
1
Tumor Necrosis Factor Inhibitors
IBA
11/2017
1
CT-P13
IBA
05/2017
1
Biosimilar Pharmaceuticals
IBA
05/2017
1
Antigens
IBA
02/2015
1
Interleukin-17 (Interleukin 17)
IBA
09/2014
1
Interleukin-2 (IL2)
IBA
09/2014
1
Gliadin
IBA
11/2013
1
Glutens (Glutelin)
IBA
11/2013
1
Enzymes
IBA
04/2013
1
Immunosorbents
IBA
04/2013
1
Interleukin-6 (Interleukin 6)
IBA
01/2010
1
Voltage-Gated Sodium Channels
IBA
01/2008
1
Local Anesthetics
IBA
01/2008
1
DNA (Deoxyribonucleic Acid)
IBA
09/2003
Therapy/Procedure
7
Therapeutics
09/2023 - 04/2013
1
Bone Marrow Transplantation (Transplantation, Bone Marrow)
11/2013
1
Brachytherapy
01/2010